PDUFA date and decision The PDUFA date is the deadline by which the FDA must make a decision
Those with preexisting diabetic retinopathy should report any visual changes, as rapid improvement in blood glucose can temporarily worsen retinopathy
When you take our free assessment quiz to determine your eligibility for our prescription weight loss medications, our medical team carefully evaluates your needs and provides clear, unambiguous dosing instructions, ensuring you receive a personalized treatment plan that prioritizes your safety
Semaglutide 2.4mg (Wegovy) typically achieves around 15% weight loss over 68 weeks, while liraglutide 3.0mg (Saxenda) typically produces 5-8% weight loss
Zepbound's potent insulin-sensitizing effect can remove this barrier in a way that diet alone can't
From prescription GLP-1 tablets and sublingual oral drops to transdermal patches and doctor-formulated supplements these alternatives deliver real weight loss results without needles